Zambon Launches Xadago® (safinamide) for Patients With Mid- to Late-Stage Parkinson’s Disease in Germany
|(Source: SYS-CON Media) These benefits have been proved at six months and maintained over two years. … Zambon SpA produces high quality products thanks to the management of the …